Related Experiment Videos
Long-term anticoagulant therapy after myocardial infarction in women
Insights
Long-term anticoagulant therapy significantly reduced mortality and reinfarction rates in women patients. This study confirms that women benefit equally from anticoagulant treatment, with no serious bleeding complications observed.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Long-term anticoagulant therapy is a common treatment for cardiovascular conditions.
- The efficacy and safety in female patients require specific evaluation.
Purpose of the Study:
- To assess the benefits of one-year anticoagulant therapy in women patients.
- To compare outcomes between treated and control groups.
Main Methods:
- A multicentre randomized trial involving 159 women patients.
- Dosage controlled by Thrombotest, aiming for 10-20% levels.
- Follow-up laboratory control and dosage management at a single center.
Main Results:
- The treatment group showed a significant reduction in mortality compared to the control group.
- A significant reduction in reinfarction rate was observed in the treatment group.
- No serious bleeding complications were reported in the treatment group.
Conclusions:
- One year of anticoagulant therapy is beneficial for women patients.
- Women patients derive as much benefit from anticoagulant therapy as men.
- The treatment is associated with a favorable safety profile.
Abstract:
A multicentre trial from five medical departments in Oslo has been carried out to determine the value in women patients of one year's long-term anticoagulant therapy. Follow-up long-term laboratory control and anticoagulant dosage were performed at one centre (the Rikshospitalet). One hundred and fifty-nine patients were assigned randomly into two similar well-matched groups (control and treatment). Dosage was controlled by Thrombotest, aiming at 10-20% levels, and 50% of the tests were less than 14%. Compared with the control group, the treatment group showed a significant reduction in mortality and in reinfarction rate. No serious bleeding complications occurred. It is concluded that women benefit as much as men from long-term anticoagulant therapy.